Highlights
- 1The Journal of biological chemistry · 2021
- 2The Journal of pharmacology and experimental therapeutics · 2021
- 3Frontiers in pharmacology · 2021
Publications
44 publications
Funding
7 grants
Active
3 grants- KPR01CA270248-01A1CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma PreventionNational Cancer Institute · 2023–2028
- KPR01DK113088-05Gene Nutrient Interactions in Kidney FunctionNational Institute of Diabetes and Digestive and Kidney Diseases · 2022–2027
- Co-IW81XWH-22-1-0873ATF4 in ccRCC: A New Therapeutic ApproachU.S. Department of Defense · 2022–2026
Completed grants (4)
- KPR01CA205258-03Characterization of Premalignant Fields in a Murine Model of Head and Neck and Esophageal CancersNational Cancer Institute · 2016–2023
- KPR01DE024394-02Oral Cancer Initiating Cells: CharacterizationNational Institute of Dental and Craniofacial Research · 2014–2018
- KPR01DE010389-20Squamous Cell Carcinomas - Effects of RetinoidsNational Institute of Dental and Craniofacial Research · 2010–2016
- KPR01AA018332-05Diet and Alcohol Induced Epigenetic Changes in an Oral Cavity Carcinogenesis ModelNational Institute on Alcohol Abuse and Alcoholism · 2010–2016
News mentions
1 mentionView all WCM news ↗
- Finding a Novel Approach to Treating Kidney DiseaseMarch 8, 2024
A new study found that retinoic acid receptors (RARa) in the proximal tubules of the kidney play a crucial role in limiting the damaging effects of kidney injury that often lead to kidney failure.